Patient ID | Gender | Type | Primary tumor grade | Metastasis resectiona | Treatmentb |
---|---|---|---|---|---|
Patient 1 | Female | Adenocarcinoma | Moderately differentiated | 3 months | No treatment |
Patient 2 | Male | Adenocarcinoma | Moderately differentiated | 20 months | No treatment |
Patient 3 | Male | Adenocarcinoma | Poorly differentiated | 10 months | XELOXc and Bevacizumab |
Patient 4 | Female | Adenocarcinoma | Well differentiated | 9 months | 5FU, leucovorin, oxaliplatin, bevacizumab |